An interventional study of ACT-based group therapy in Neurological Disorders, Mental Health and Executive Function (Cognition), sponsored by Bielefeld University. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-27.
Sponsored by Bielefeld University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Brain Injuries with a site in Germany — 5 open to participants now, 5 under way, none of them phase 3. Brain Injuries · Germany.
Among the 20 studies in Brain Injuries with a site in Germany, this one is the only one that started in 2024, is one of 7 with no phase, and was the 18th registered.
947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.
Browse Brain Injuries studies →5 of the 20 studies in Brain Injuries with a site in Germany are open now. Recruiting first, the newest first:
BDH-Klinik Hessisch Oldendorf · Sites in Germany
Ages 18+
Lund University · Sites in Germany, Finland, Sweden
Ages 18–100
Ludwig-Maximilians - University of Munich · Sites in Germany
Ages 18+
BDH-Klinik Hessisch Oldendorf · Sites in Germany
Ages 18–80
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 152 Brain Injuries studies recruiting now, 77 (51%) set no upper age limit and 53 (35%) stop at 75 or younger; 38 take children under 18; 23 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 1 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 44 is close to the median of 41 across 613 interventional studies indexed under Brain Injuries.
Median enrollment 47 across the 9 interventional studies, 100 across the 11 observational. Of the 11 that completed or were terminated, 1 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 20 have an industry lead sponsor. The 10 most frequent:
Bielefeld University is the lead sponsor of 10 studies on the registry; 5 are open to participants now.
Bielefeld University has 1 study filed under Brain Injuries — fewer than ten, so there is no comparison to draw.
3 of the studies in Brain Injuries with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06121336Ludwig-Maximilians - University of MunichPRecisiOn Medicine In StrokE: Evolution of Plasma Brain-Derived Tau in Acute Stroke | 2026-12-31 |
| NCT07455682BDH-Klinik Hessisch OldendorfAuditory Processing in DOC Patients | 2027-11-30 |
| NCT07456020BDH-Klinik Hessisch OldendorfAssessment of Consciousness With CRS-R and SECONDs | 2027-11-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 20 studies in Brain Injuries with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to examine the efficacy of this manual for mental health in people with mixed neurological disorders, including post-COVID. These conditions are often associated with cognitive impairment, which may hamper the effects of psychoterapy. Executive functioning and especially the ability to abstract thinking may be useful for individuals using Acceptance and Commitment Therapy. Therefore, the main questions research questions are:
Mental health issues, especially depression, anxiety, and stress, are common in people with neurological disorders and post-COVID but often neglected and hence, remain untreated. Acceptance and Commitment Therapy (ACT) is a promising approach to assist people in adapting to their conditions by improving "psychological flexibility".
A previous study translated an adapted group psychotherapy manual for stroke survivors into German and demonstrated its feasibility. This pilot study also gave first indications on the manual's efficacy in reducing symptoms of anxiety, depression, and stress. The aim of this study is to investigate the efficacy of this ACT-based group therapy. People with neurological disorders may have impairments in executive functions, which can affect the psychotherapeutic process. Since ACT often uses metaphors and imagery, executive functions, particularly the ability to abstract, could influence the efficacy of the therapy and are therefore being investigated in this study. The program includes 8 weekly sessions with a session length of 100 minutes.
947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.
This study's planned enrollment of 44 is close to the median of 41 across 613 interventional studies indexed under Brain Injuries.
Browse Brain Injuries studies →Bielefeld University is the lead sponsor of 10 studies on the registry; 5 are open to participants now.
Compared within Brain Injuries, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Nervous System Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Eight weeks of waiting list are followed by eight weeks of ACT group therapy, see study design.
Behavioral: ACT-based group therapy
ACT-based group therapy based on the manual "Living Well with Neurological Conditions" published by Hill et al. (2017; NHS Fundation Trust; available: https://goo.gl/aX6qB5). The manual was translated into German and adapted by shortening sessions, simplifying language and adapting exercises based on clinical experience. The publication of the feasibility study for the adapted manual is currently in preparation. The group therapy includes eight weekly sessions with a duration of 100 minutes each. Three to six individuals participate in a group. The therapy is delivered by at least one licensed psychotherapists. A co-therapist might be included based on individual needs of the group members.
Depression and Anxiety Stress Scales-21 (Lovibond, 1995)
Measure of psychological burden to investigate efficacy. Scores range from 0 to 63 with higher values indicating higher burden.
Time frame: Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart)
Acceptance and Action Questionnaire-Acquired Brain Injury (Sylvester, 2011)
Measure of psychological flexibility to investigate efficacy. Scores range from 0 to 36 with higher values indicating higher inflexibility.
Time frame: Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart)
Wechsler Adult Intelligence Scale - Fourth Edition (Similarities subtest; Wechsler, 2008)
Measure of individual's ability to recognize and articulate the commonalities between different objects, reflecting their abstraction ability. This will be used to examine the influence of the ability of abstract thinking. Scores range from 0 to 36 with higher values indicating higher ability of abstraction.
Time frame: pre- and post-intervention (pre and post are presumably 8 weeks apart)
Patient Health Questionnaire-9 (Kroenke, 2001)
Measure of depressive symptoms to investigate efficacy. Scores range from 0 to 27 with higher values indicating more severe depressive symptoms.
Time frame: Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart)
Generalized Anxiety Disorder Scale-7 (GAD-7; Spitzer et al., 2007)
Measure of anxiety symptoms to investigate efficacy. Scores range from 0 to 21 with higher scores indicating higher anxiety.
Time frame: Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart)
Valuing Questionnaire (Smout, 2014)
Measure of valued living to investigate efficacy. Scores range from 0 to 60 with higher values indicating higher value-congruent living.
Time frame: Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart)
Self-as-context scale (Zettle, 2018)
Measure of self as context to investigate efficacy. Scores range from 10 to 70 with higher values indicating a perspective closer to self-as-context.
Time frame: Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart)
World Health Organization Disability Assessment Schedule 2.0 (V.S. Üstün, 2010; Plain German)
Measure of functional impairments and disabilities.
Time frame: Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart)
Regensburg Word Fluency Test (Aschenbrenner, 2001)
Measure of verbal fluency.
Time frame: pre- and post-intervention (pre and post are presumably 8 weeks apart)
Stroop Test in Vienna Test System (Müller & Ziegler, 2001)
Measure of cognitive flexibility and inhibition of irrelevant stimuli.
Time frame: pre- and post-intervention (pre and post are presumably 8 weeks apart)
Group therapy session questionnaire (Zoubek, 2013; Plain German)
Measure of treatment acceptance and satisfaction for patients regarding each session (GTS-P Session), for patients regarding the entire therapy (GTS-P Total), and for therapists regarding the each session (GTS-T). GTS-P Session scores from 0 to 24 with higher values indicating higher acceptance. GTS-P Total scores from 0 to 8 with higher values indicating higher acceptance. GTS-T scores from 0 to 48 with higher values indicating higher acceptance.
Time frame: GTS-P Session and GTS-T during the intervention (weekly, after each session), GTS-P Total post-intervention
Plan to share: Yes — IPD will be shared on public repository like Mendeley Data, while ensuring that no individual may be identified by the data.
Time frame: IPD will be available latest six months after completion of data collection, presumably January, 1st, 2027. Data will be deleted after ten years.
Started Dec 2024 (actual). Primary completion is estimated for Aug 2026, 20 months after the start.
Of 285 non-industry interventional studies with no phase under Brain Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 20 months is below that.
Counting every sponsor, half of 298 studies reached it within 24 months; a quarter within 12 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bielefeld University